These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28209929)

  • 1. Ampicillin/sulbactam-induced Kounis syndrome with cardiogenic shock.
    Kounis NG; Koniari I
    Anatol J Cardiol; 2017 Feb; 17(2):154-155. PubMed ID: 28209929
    [No Abstract]   [Full Text] [Related]  

  • 2. Kounis syndrome presenting with acute inferior wall myocardial infarction and cardiogenic shock secondary to intravenous ampicillin/sulbactam administration.
    Keskin M; Hayıroğlu Mİ; Onuk T; Keskin Ü; Ekmekçi A
    Anatol J Cardiol; 2016 Nov; 16(11):893-894. PubMed ID: 27872436
    [No Abstract]   [Full Text] [Related]  

  • 3. Kounis syndrome, a disease to know: Case report and review of the literature.
    Sciatti E; Vizzardi E; Cani DS; Castiello A; Bonadei I; Savoldi D; Metra M; D'Aloia A
    Monaldi Arch Chest Dis; 2018 Mar; 88(1):898. PubMed ID: 29557575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary spasm secondary to cefuroxime injection, complicated with cardiogenic shock - a manifestation of Kounis syndrome: case report and literature review.
    Mitsis A; Christodoulou E; Georgiou P
    Eur Heart J Acute Cardiovasc Care; 2018 Oct; 7(7):624-630. PubMed ID: 28345355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probable sulbactam/ampicillin-associated prolonged cholestasis.
    Köklü S; Köksal AS; Asil M; Kiyici H; Coban S; Arhan M
    Ann Pharmacother; 2004 Dec; 38(12):2055-8. PubMed ID: 15494387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pseudo-membranous colitis induced by ampicillin-sulbactam combination].
    Durieu I; Chiappini J; Bonvoisin S; Grange C; Levrat R
    Therapie; 1994; 49(1):51. PubMed ID: 8091366
    [No Abstract]   [Full Text] [Related]  

  • 7. Kounis syndrome secondary to simultaneous oral amoxicillin and parenteral ampicillin use in a young man.
    Bezgin T; Geçmen Ç; Özkan B; Alici G; Kalkan ME; Kargin R; Esen AM
    Cardiovasc J Afr; 2013 Mar; 24(2):e10-2. PubMed ID: 23152096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam).
    Coccolini F; Catena F; Ansaloni L; Ercolani G; Di Saverio S; Gazzotti F; Lazzareschi D; Pinna AD
    BMC Gastroenterol; 2011 Apr; 11():42. PubMed ID: 21501482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ampicillin and sulbactam in pediatric patients.
    Nahata MC; Vashi VI; Swanson RN; Messig MA; Chung M
    Antimicrob Agents Chemother; 1999 May; 43(5):1225-9. PubMed ID: 10223940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections.
    Betrosian AP; Douzinas EE
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K deficiency due to prolongation of antibiotic treatment and decrease in food intake in a catatonia patient.
    Nomoto H; Hatta K; Usui C; Ito M; Kita Y; Arai H
    Psychosomatics; 2011; 52(5):486-7. PubMed ID: 21907073
    [No Abstract]   [Full Text] [Related]  

  • 12. Unasyn (ampicillin sodium/sulbactam sodium).
    Claussen DW
    Gastroenterol Nurs; 1993 Aug; 16(1):36-8. PubMed ID: 8399439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The efficacy of the combined preparation ampicillin/sulbactam (Unasyn) in treating postoperative suppurative complications in a surgical hospital].
    Ginters Ia; Ginters G; Leĭtans G
    Antibiot Khimioter; 1991 Jun; 36(6):11-2. PubMed ID: 1898181
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation of sulbactam + ampicillin in the treatment of pediatric urinary tract infections.
    Solbiati M; Danzi MC; D'Orazio C; Bassetti D
    Chemioterapia; 1988 Dec; 7(6):393-5. PubMed ID: 3219751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cardiogenic shock on pharmacokinetics and tissue distribution of ampicillin-sulbactam.
    Arden WA; Barker DE; Strodel WE; Record K; Leader G; Derbin M; Gellin G; Schwartz RW
    Circ Shock; 1994 Nov; 44(3):138-47. PubMed ID: 7600637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical and bacteriological efficacy of the combined preparation ampicillin/sulbactam (Unasyn) in treating different infections].
    Strachunskiĭ LS; Novikova IuA; Prokhorenkov PI; Iakusheva LV
    Antibiot Khimioter; 1991 Jun; 36(6):18-21. PubMed ID: 1898183
    [No Abstract]   [Full Text] [Related]  

  • 17. Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients.
    Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):270-3. PubMed ID: 19346879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of sulbactam-ampicillin/sultamicillin in mixed infections.
    Moosdeen F
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S1. PubMed ID: 10526866
    [No Abstract]   [Full Text] [Related]  

  • 19. Death following ceftazidime-induced Kounis syndrome.
    Kitulwatte I; Gangahawatte S; Perera U; Edirisinghe P
    Med Leg J; 2017 Dec; 85(4):215-218. PubMed ID: 29210337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ampicillin/sulbactam: current status in severe bacterial infections.
    Rafailidis PI; Ioannidou EN; Falagas ME
    Drugs; 2007; 67(13):1829-49. PubMed ID: 17722953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.